Bristol-Myers Squibb Company

NYSE: BMY
$56.81
-$0.33 (-0.6%)
Closing Price on January 8, 2025

BMY Articles

The fight against melanoma just got a new weapon after a drug called Yervoy, or ipilimumab, was given FDA approval for late-stage metastatic melanoma.  The approval is a win for Bristol-Myers...
Earnings season may still be in force, but we are looking for the coming week’s top coming events that could have a large impact on shares on Monday and throughout the week.  What has been known...
Dell’s (NASDAQ: DELL) margins rushed past expectations and shares moved higher (Reuters) Bernanke said a strong US recovery is essential to global economic health (Reuters) Lawmakers attacked...
Bristol-Myers Squibb (NYSE: BMY) will cut nearly 1,000 workers. That is on top of large rounds of firings in 2007 and 2008. The company gave an odd reason for the action.”The ultimate goal of the...
Reuters: Petrobras raised $70 billion in the largest stock offer in history. Reuters:   There will likely be no tax cut before the election, according to Democrats Reuters:   Obama asked the...
Reuters:   Japan’s plan to intervene in yen trading has not moved the currency lower. Reuters:   Oil dropped as investor moved away from risk Reuters:   Hewlett-Packard (NYSE: HPQ) sued to...
These are some of this Friday’s top analyst calls with upgrades, downgrades, and initiations seen in Wall Street research notes: American Eagle Outfitters, Inc. (NYSE: AEO) Raised to Buy at...
Today’s edition of the BioHealth Business Daily is going to be very cancer-dominated due to the American Society of Clinical Oncology (ASCO) 2010 meeting that started this last weekend.  There are...
We have several big movers on news this morning, and none appear to be based upon earnings.  Stocks on the move are ArQule Inc. (NASDAQ: ARQL), BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX),...
These are some of the major research calls we have seen from analysts in their upgrades, downgrades, and initiations so far this Monday: Amazon.com, Inc. (NASDAQ: AMZN) Raised to Conviction Buy List...
The pharmaceutical industry has found a growing source of sales–the prescription of medicines, primarily used by adults in the past, to children. A portion of the sharp increase in drugs used by...
A look at the “hardest working” major brands for 2009 shows that a number of them belong to companies which have done poorly and, in at least one case, may file Chapter 11. This is due to the...
Reuters:   The Senate overcame opposition to allow jobless benefits to be extended. Reuters:   China will hope to keep the value of the yuan steady. Reuters:   JC Penney (JCP) will focus on...
There are twelve major pharmaceutical firms that dominate this industry worldwide. Their combined market value is over $1 trillion with total  annual sales  of over $500 billion. The firms have...
Short sellers sharply increased their bets against two of America’s most widely followed stocks. Shares sold short in Citigroup (NYSE:C) rose 36% to 381 million. The short interest in Apple...
AI Portfolio

Discover Our Top AI Stocks

Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.

You can follow him investing $500,000 of his own money on our top AI stocks for free.